美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Roivant Sciences Ltd.

34.21

-0.5400-1.55%

盤後：34.210.00000.00%16:42 EDT

成交量：627.94萬

成交額：2.14億

市值：247.14億

市盈率：-72.79

高：34.56

開：34.28

低：33.32

收：34.75

52周最高：42.50

52周最低：15.90

股本：7.22億

流通股本：5.81億

量比：1.24

換手率：1.08%

股息：- -

股息率：- -

每股收益(TTM):-0.4700

每股收益(LYR):-0.5400

淨資產收益率：-8.52%

總資產收益率：-16.48%

市淨率：5.84

市盈率(LYR):-63.35

資料載入中...

總覽公司新聞資訊公告

Roivant（ROIV）跌2.93% 皮膚紅斑狼瘡試驗失利

Immunovant股價因狼瘡藥物研發受挫而下跌

Roivant公布Imvt-1402在皮膚紅斑狼瘡概念驗證研究中的頂線結果

BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華

異動解讀｜Roivant Sciences盤中上漲14.2%，核心管線Mosliciguat二期臨床達主要終點

Roivant公司實驗性肺部疾病藥物在中期研究中達到預期目標

實驗性肺病藥物中期研究達主要終點 Roivant Sciences股價盤前飆升21.1%

異動解讀｜Roivant Sciences盤前上漲28.66%，核心管線Mosliciguat臨床研究獲積極數據

Roivant公布Mosliciguat治療間質性肺病相關肺動脈高壓（Ph-Ild）的Phocus研究積極結果，並披露正在進行的Phrontier III期試驗

Roivant和Priovant推出新獲批的罕見病藥物Lisraya，每月售價35,000美元

Priovant宣佈FDA批准Lisraya™（Brepocitinib）用於成人皮肌炎治療；現已在美國上市

美國FDA批准了Roivant-Priovant公司的一款皮膚病藥物

《JAMA皮膚病學》發布Brepocitinib治療皮肌炎3期VALOR試驗皮膚特異性結果

Roivant Sciences：Brepocitinib新藥申請獲批，皮肌炎產品預計2026年9月底前上市

財報前瞻｜Roivant Sciences Ltd.本季度營收預計大幅下滑，機構觀點偏謹慎

Roivant Sciences 將於2026年8月6日公布第一財季業績並更新業務動態

異動解讀 | Roivant Sciences盤中大漲15.99%，財報及關節炎藥物進展提振股價

市場快訊——美股行情動態-皇家加勒比郵輪、AMC娛樂、Roivant

異動解讀｜Roivant Sciences盤中上漲11.1%，公布財年業績及業務進展獲市場積極反應

異動解讀｜Roivant Sciences盤前上漲8.12%，公布財年業績及業務進展

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/ROIV/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ROIV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","market":"US","secType":"STK","nameCN":"Roivant Sciences Ltd.","latestPrice":34.21,"timestamp":1791489600000,"preClose":34.75,"halted":0,"volume":6279442,"hourTrading":{"tag":"盘后","latestPrice":34.21,"preClose":34.21,"latestTime":"16:42 EDT","volume":279788,"amount":9571547.48,"timestamp":1791492132590,"change":0,"changeRate":0,"amplitude":0.000877},"delay":0,"changeRate":-0.015539568345323716,"floatShares":581000000,"shares":722406273,"eps":-0.47,"marketStatus":"盤後交易","change":-0.54,"latestTime":"10-08 16:57:19 EDT","open":34.275,"high":34.56,"low":33.32,"amount":213815521.293686,"amplitude":0.035683,"askPrice":34.88,"askSize":57,"bidPrice":33.54,"bidSize":59,"shortable":3,"etf":0,"ttmEps":-0.47,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"listingDate":1607403600000,"exchange":"NASDAQ","adjPreClose":34.75,"preHourTrading":{"tag":"盘前","latestPrice":34.55,"preClose":34.75,"latestTime":"09:27 EDT","volume":2553,"amount":87115.319478,"timestamp":1791466046949,"change":-0.2,"changeRate":-0.005755,"amplitude":0.05775},"postHourTrading":{"tag":"盘后","latestPrice":34.21,"preClose":34.21,"latestTime":"16:42 EDT","volume":279788,"amount":9571547.48,"timestamp":1791492132590,"change":0,"changeRate":0,"amplitude":0.000877},"volumeRatio":1.240032,"impliedVol":0.4604,"impliedVolPercentile":0.7849},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","floatShares":581000000,"roa":"-16.48%","roe":"-8.52%","lyrEps":-0.539999,"volumeRatio":1.240032,"shares":722406273,"dividePrice":0,"high":34.56,"amplitude":0.035683,"preClose":34.75,"low":33.32,"week52Low":15.9,"pbRate":"5.84","psRate":"3281.14","week52High":42.5,"institutionHeld":0,"latestPrice":34.21,"committee":0.017241,"eps":-0.47,"divideRate":0,"volume":6279442,"delay":0,"ttmEps":-0.47,"open":34.275,"prevYearClose":21.7,"prevWeekClose":35.72,"prevMonthClose":36.57,"prevQuarterClose":36.57,"fiveDayClose":35.5,"twentyDayClose":40.94,"sixtyDayClose":34.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ROIV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ROIV","fiscalQuarterEnding":"2026/06","expectedEps":-0.45,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2026-05-20","symbol":"ROIV","fiscalQuarterEnding":"2026/03","expectedEps":-0.38,"name":null,"time":"盤前","type":"earning","dateTimestamp":1779249600000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2026-02-06","symbol":"ROIV","fiscalQuarterEnding":"2025/12","expectedEps":-0.38,"name":null,"time":"盤前","type":"earning","dateTimestamp":1770354000000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2025-11-10","symbol":"ROIV","fiscalQuarterEnding":"2025/09","expectedEps":-0.34,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2025-08-11","symbol":"ROIV","fiscalQuarterEnding":"2025/06","expectedEps":-0.31,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ROIV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ROIV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.4286,"hold":0.0714,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":14,"updateTime":1789617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ROIV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ROIV","date":"2026-10-07","current":-73.93617,"percent":0.028109,"low":-113.427174,"twenty":-41.710751,"median":-5.614485,"eighty":-1.994349,"high":2.128992,"avg":-19.85113,"sd":27.684836,"marketCap":25664136722},"quantilePoints":[{"date":"2021-10-08","current":-5.068762,"twenty":-7.200647,"median":-5.392973,"eighty":-5.011828,"marketCap":4501942504},{"date":"2021-10-15","current":-4.760366,"twenty":-6.226432,"median":-5.064808,"eighty":-4.897958,"marketCap":4228033366},{"date":"2021-10-22","current":-5.377158,"twenty":-5.411951,"median":-4.997594,"eighty":-4.833116,"marketCap":4775851643},{"date":"2021-10-29","current":-6.278622,"twenty":-6.291275,"median":-5.22296,"eighty":-4.848931,"marketCap":5576509124},{"date":"2021-11-05","current":-6.120471,"twenty":-6.278622,"median":-5.416696,"eighty":-4.897958,"marketCap":5436042899},{"date":"2021-11-12","current":-6.642371,"twenty":-6.291275,"median":-5.970226,"eighty":-4.945404,"marketCap":5899581441},{"date":"2021-11-19","current":-5.294334,"twenty":-6.278622,"median":-5.426692,"eighty":-4.965964,"marketCap":5618648992},{"date":"2021-11-26","current":-4.632542,"twenty":-6.278622,"median":-5.392973,"eighty":-4.942241,"marketCap":4916317868},{"date":"2021-12-03","current":-5.94289,"twenty":-6.246992,"median":-5.404834,"eighty":-4.886887,"marketCap":6306933493},{"date":"2021-12-10","current":-5.9098,"twenty":-6.278622,"median":-5.56694,"eighty":-4.942241,"marketCap":6271816937},{"date":"2021-12-17","current":-7.24662,"twenty":-6.278622,"median":-5.70859,"eighty":-4.958056,"marketCap":7690525807},{"date":"2021-12-23","current":-7.915029,"twenty":-6.461382,"median":-5.896565,"eighty":-4.962362,"marketCap":8399880243},{"date":"2021-12-31","current":-6.670861,"twenty":-6.679397,"median":-5.936272,"eighty":-4.990763,"marketCap":7079497729},{"date":"2022-01-07","current":-5.658319,"twenty":-6.654395,"median":-5.93348,"eighty":-5.048202,"marketCap":6004931110},{"date":"2022-01-14","current":-5.261244,"twenty":-6.643953,"median":-5.883329,"eighty":-5.051959,"marketCap":5583532435},{"date":"2022-01-21","current":-4.79799,"twenty":-6.611816,"median":-5.850239,"eighty":-4.961285,"marketCap":5091900649},{"date":"2022-01-28","current":-4.420769,"twenty":-6.571592,"median":-5.612629,"eighty":-4.867909,"marketCap":4691571908},{"date":"2022-02-04","current":-4.718575,"twenty":-6.480662,"median":-5.4664,"eighty":-4.79799,"marketCap":5007620914},{"date":"2022-02-11","current":-4.533273,"twenty":-6.411262,"median":-5.421694,"eighty":-4.75404,"marketCap":4810968199},{"date":"2022-02-18","current":-4.229896,"twenty":-6.336473,"median":-5.386985,"eighty":-4.697398,"marketCap":4588438579},{"date":"2022-02-25","current":-4.197996,"twenty":-6.294119,"median":-5.373749,"eighty":-4.638618,"marketCap":4553834970},{"date":"2022-03-04","current":-3.611042,"twenty":-6.287633,"median":-5.300952,"eighty":-4.614157,"marketCap":3917128561},{"date":"2022-03-11","current":-3.209106,"twenty":-6.278622,"median":-5.214919,"eighty":-4.599453,"marketCap":3481123085},{"date":"2022-03-18","current":-3.311185,"twenty":-6.26597,"median":-5.064808,"eighty":-4.551803,"marketCap":3591854634},{"date":"2022-03-25","current":-3.177207,"twenty":-6.224851,"median":-4.997594,"eighty":-4.245208,"marketCap":3446519476},{"date":"2022-04-01","current":-3.087888,"twenty":-6.188476,"median":-4.960747,"eighty":-4.132921,"marketCap":3349629370},{"date":"2022-04-08","current":-2.647672,"twenty":-6.180568,"median":-4.886887,"eighty":-3.804992,"marketCap":2872099563},{"date":"2022-04-14","current":-2.580683,"twenty":-6.166298,"median":-4.831534,"eighty":-3.511515,"marketCap":2799431984},{"date":"2022-04-22","current":-2.494554,"twenty":-6.126648,"median":-4.804608,"eighty":-3.330325,"marketCap":2706002239},{"date":"2022-04-29","current":-2.354195,"twenty":-6.120471,"median":-4.79799,"eighty":-3.283114,"marketCap":2553746358},{"date":"2022-05-06","current":-2.309536,"twenty":-6.09833,"median":-4.74149,"eighty":-3.183587,"marketCap":2505301306},{"date":"2022-05-13","current":-2.207457,"twenty":-5.999036,"median":-4.718575,"eighty":-3.099372,"marketCap":2394569756},{"date":"2022-05-20","current":-2.360575,"twenty":-5.953479,"median":-4.649087,"eighty":-2.763787,"marketCap":2560667080},{"date":"2022-05-27","current":-2.577493,"twenty":-5.941566,"median":-4.632542,"eighty":-2.637464,"marketCap":2795971623},{"date":"2022-06-03","current":-2.781651,"twenty":-5.936272,"median":-4.625924,"eighty":-2.634912,"marketCap":3017434722},{"date":"2022-06-10","current":-2.469034,"twenty":-5.930689,"median":-4.602882,"eighty":-2.583873,"marketCap":2678319352},{"date":"2022-06-17","current":-2.794411,"twenty":-5.9098,"median":-4.599453,"eighty":-2.577493,"marketCap":3031276165},{"date":"2022-06-24","current":-3.055988,"twenty":-5.888623,"median":-4.592835,"eighty":-2.577493,"marketCap":3315025761},{"date":"2022-07-01","current":-3.664409,"twenty":-5.883329,"median":-4.477021,"eighty":-2.580045,"marketCap":3097385357},{"date":"2022-07-08","current":-4.01261,"twenty":-5.863475,"median":-4.327927,"eighty":-2.582597,"marketCap":3391707043},{"date":"2022-07-15","current":-3.540051,"twenty":-5.794648,"median":-4.223516,"eighty":-2.595357,"marketCap":2992270469},{"date":"2022-07-22","current":-3.564922,"twenty":-5.698027,"median":-4.143766,"eighty":-2.610669,"marketCap":3013293447},{"date":"2022-07-29","current":-3.311167,"twenty":-5.603492,"median":-4.012978,"eighty":-2.627256,"marketCap":2798803556},{"date":"2022-08-05","current":-3.136457,"twenty":-5.546323,"median":-3.998124,"eighty":-2.642568,"marketCap":2651127991},{"date":"2022-08-12","current":-3.635628,"twenty":-5.492872,"median":-3.896543,"eighty":-2.647672,"marketCap":3073058176},{"date":"2022-08-19","current":-2.37779,"twenty":-5.442575,"median":-3.739024,"eighty":-2.627256,"marketCap":2603414024},{"date":"2022-08-26","current":-2.409923,"twenty":-5.426692,"median":-3.722442,"eighty":-2.582597,"marketCap":2638595295},{"date":"2022-09-02","current":-2.262114,"twenty":-5.420694,"median":-3.686206,"eighty":-2.571113,"marketCap":2476761450},{"date":"2022-09-09","current":-2.319952,"twenty":-5.407207,"median":-3.656118,"eighty":-2.54405,"marketCap":2540087737},{"date":"2022-09-16","current":-2.0886,"twenty":-5.390578,"median":-3.622956,"eighty":-2.522626,"marketCap":2286782589},{"date":"2022-09-23","current":-1.923582,"twenty":-5.383054,"median":-3.581602,"eighty":-2.479242,"marketCap":2106106321},{"date":"2022-09-30","current":-2.071549,"twenty":-5.375794,"median":-3.540051,"eighty":-2.458826,"marketCap":2268114499},{"date":"2022-10-07","current":-2.830689,"twenty":-5.36316,"median":-3.496169,"eighty":-2.456274,"marketCap":3099286894},{"date":"2022-10-14","current":-2.946489,"twenty":-5.331394,"median":-3.460918,"eighty":-2.458826,"marketCap":3226075903},{"date":"2022-10-21","current":-2.856422,"twenty":-5.302276,"median":-3.442407,"eighty":-2.462654,"marketCap":3127462229},{"date":"2022-10-28","current":-3.377526,"twenty":-5.281098,"median":-3.377526,"eighty":-2.464697,"marketCap":3698012771},{"date":"2022-11-04","current":-3.538361,"twenty":-5.242714,"median":-3.39361,"eighty":-2.46827,"marketCap":3874108617},{"date":"2022-11-11","current":-3.413882,"twenty":-5.212272,"median":-3.409693,"eighty":-2.479242,"marketCap":3737818266},{"date":"2022-11-18","current":-3.079035,"twenty":-5.152485,"median":-3.375884,"eighty":-2.494554,"marketCap":3627093935},{"date":"2022-11-25","current":-3.177564,"twenty":-5.06718,"median":-3.35355,"eighty":-2.494554,"marketCap":3743160940},{"date":"2022-12-02","current":-3.879584,"twenty":-5.051959,"median":-3.352764,"eighty":-2.499658,"marketCap":4570138358},{"date":"2022-12-09","current":-4.310649,"twenty":-5.012624,"median":-3.375884,"eighty":-2.52135,"marketCap":5077931509},{"date":"2022-12-16","current":-4.507707,"twenty":-4.994734,"median":-3.411571,"eighty":-2.52773,"marketCap":5310065520},{"date":"2022-12-23","current":-4.316807,"twenty":-4.979321,"median":-3.429759,"eighty":-2.532833,"marketCap":5085185696},{"date":"2022-12-30","current":-4.920298,"twenty":-4.963438,"median":-3.442407,"eighty":-2.532833,"marketCap":5796096108},{"date":"2023-01-06","current":-5.696215,"twenty":-4.986152,"median":-3.459421,"eighty":-2.537937,"marketCap":6710123779},{"date":"2023-01-13","current":-6.078015,"twenty":-5.062436,"median":-3.489823,"eighty":-2.548887,"marketCap":7159883427},{"date":"2023-01-20","current":-5.406785,"twenty":-5.233449,"median":-3.502516,"eighty":-2.555534,"marketCap":6369176949},{"date":"2023-01-27","current":-5.26515,"twenty":-5.262806,"median":-3.539206,"eighty":-2.566009,"marketCap":6202330628},{"date":"2023-02-03","current":-4.803295,"twenty":-5.259893,"median":-3.564922,"eighty":-2.571113,"marketCap":5658266538},{"date":"2023-02-10","current":-5.115464,"twenty":-5.244212,"median":-3.604662,"eighty":-2.574941,"marketCap":6026001052},{"date":"2023-02-17","current":-5.249117,"twenty":-5.262806,"median":-3.622956,"eighty":-2.577493,"marketCap":6537643757},{"date":"2023-02-24","current":-4.707155,"twenty":-5.260343,"median":-3.647828,"eighty":-2.578769,"marketCap":5862643415},{"date":"2023-03-03","current":-4.902017,"twenty":-5.255042,"median":-3.686206,"eighty":-2.581959,"marketCap":6105340167},{"date":"2023-03-10","current":-4.658439,"twenty":-5.243214,"median":-3.722442,"eighty":-2.58884,"marketCap":5801969227},{"date":"2023-03-17","current":-5.297833,"twenty":-5.243214,"median":-3.739024,"eighty":-2.598979,"marketCap":6598317945},{"date":"2023-03-24","current":-4.213908,"twenty":-5.243214,"median":-3.8468,"eighty":-2.606589,"marketCap":5248317262},{"date":"2023-03-31","current":-4.494023,"twenty":-5.232955,"median":-3.897301,"eighty":-2.613481,"marketCap":5597193843},{"date":"2023-04-06","current":-4.329608,"twenty":-5.228412,"median":-3.950432,"eighty":-2.619601,"marketCap":5392418458},{"date":"2023-04-14","current":-4.627992,"twenty":-5.217919,"median":-4.01261,"eighty":-2.637464,"marketCap":5764047860},{"date":"2023-04-21","current":-5.358727,"twenty":-5.233657,"median":-4.051523,"eighty":-2.647672,"marketCap":6674160680},{"date":"2023-04-28","current":-5.133417,"twenty":-5.258992,"median":-4.076932,"eighty":-2.647672,"marketCap":6393542560},{"date":"2023-05-05","current":-5.115149,"twenty":-5.249117,"median":-4.210756,"eighty":-2.654052,"marketCap":6370789740},{"date":"2023-05-12","current":-5.510964,"twenty":-5.261296,"median":-4.226706,"eighty":-2.654128,"marketCap":6863767517},{"date":"2023-05-19","current":-5.535322,"twenty":-5.302098,"median":-4.268175,"eighty":-2.724231,"marketCap":6894104611},{"date":"2023-05-26","current":-5.620574,"twenty":-5.32219,"median":-4.304491,"eighty":-2.730611,"marketCap":7000284440},{"date":"2023-05-31","current":-5.523143,"twenty":-5.32219,"median":-4.313728,"eighty":-2.730611,"marketCap":6878936064},{"date":"2023-06-09","current":-5.833705,"twenty":-5.36774,"median":-4.329608,"eighty":-2.730865,"marketCap":7265734013},{"date":"2023-06-16","current":-6.040747,"twenty":-5.386985,"median":-4.34784,"eighty":-2.731246,"marketCap":7523599312},{"date":"2023-06-23","current":-6.071194,"twenty":-5.402439,"median":-4.369153,"eighty":-2.743893,"marketCap":7561520679},{"date":"2023-06-30","current":-7.523496,"twenty":-5.414714,"median":-4.379957,"eighty":-2.752698,"marketCap":7591433186},{"date":"2023-07-07","current":-8.093458,"twenty":-5.42245,"median":-4.39535,"eighty":-2.763985,"marketCap":8166541761},{"date":"2023-07-10","current":-8.20745,"twenty":-5.426692,"median":-4.40302,"eighty":-2.769628,"marketCap":8281563476},{"date":"2023-07-21","current":-8.458233,"twenty":-5.426692,"median":-4.411894,"eighty":-2.775271,"marketCap":8534611249},{"date":"2023-07-28","current":-8.20745,"twenty":-5.456159,"median":-4.423904,"eighty":-2.776851,"marketCap":8281563476},{"date":"2023-08-02","current":-9.084475,"twenty":-5.504874,"median":-4.43381,"eighty":-2.779221,"marketCap":9166507826},{"date":"2023-08-11","current":-8.673275,"twenty":-5.533128,"median":-4.451397,"eighty":-2.781165,"marketCap":8751594647},{"date":"2023-08-17","current":-8.609097,"twenty":-5.568907,"median":-4.464601,"eighty":-2.789307,"marketCap":8342533149},{"date":"2023-08-25","current":-8.848017,"twenty":-5.635672,"median":-4.494023,"eighty":-2.794411,"marketCap":8574055808},{"date":"2023-09-01","current":-9.214361,"twenty":-5.70006,"median":-4.494023,"eighty":-2.796878,"marketCap":8929057219},{"date":"2023-09-08","current":-9.317894,"twenty":-5.725205,"median":-4.506954,"eighty":-2.804955,"marketCap":9029383704},{"date":"2023-09-15","current":-9.150649,"twenty":-5.757588,"median":-4.518382,"eighty":-2.830689,"marketCap":8867317843},{"date":"2023-09-19","current":-8.855981,"twenty":-5.782386,"median":-4.524471,"eighty":-2.831089,"marketCap":8581773230},{"date":"2023-10-05","current":-7.985677,"twenty":-5.795976,"median":-4.528872,"eighty":-2.831489,"marketCap":7738416687},{"date":"2023-10-09","current":-8.819584,"twenty":-5.801844,"median":-4.533273,"eighty":-2.83189,"marketCap":8546503125},{"date":"2023-11-10","current":-6.982171,"twenty":-5.878767,"median":-4.593193,"eighty":-2.839209,"marketCap":6765981641},{"date":"2023-11-17","current":-7.385988,"twenty":-5.911027,"median":-4.599453,"eighty":-2.843555,"marketCap":7251370631},{"date":"2023-11-24","current":-7.476061,"twenty":-5.936844,"median":-4.606312,"eighty":-2.848702,"marketCap":7339801980},{"date":"2023-12-01","current":-7.828164,"twenty":-5.955617,"median":-4.626958,"eighty":-2.858995,"marketCap":7685488163},{"date":"2023-12-08","current":-7.983745,"twenty":-6.044634,"median":-4.632542,"eighty":-2.865429,"marketCap":7838233221},{"date":"2023-12-15","current":-9.113752,"twenty":-6.115375,"median":-4.64756,"eighty":-2.880169,"marketCap":8947644692},{"date":"2023-12-22","current":-8.630633,"twenty":-6.163796,"median":-4.652396,"eighty":-2.903623,"marketCap":8473331092},{"date":"2023-12-29","current":-9.310275,"twenty":-6.191639,"median":-4.65697,"eighty":-2.914323,"marketCap":9140585817},{"date":"2024-01-05","current":-8.85991,"twenty":-6.278622,"median":-4.665632,"eighty":-2.914323,"marketCap":8698429071},{"date":"2024-01-12","current":-8.999114,"twenty":-6.411262,"median":-4.682797,"eighty":-2.933623,"marketCap":8835095702},{"date":"2024-01-19","current":-8.606068,"twenty":-6.622001,"median":-4.702881,"eighty":-2.951636,"marketCap":8449213451},{"date":"2024-01-26","current":-8.614256,"twenty":-6.787201,"median":-4.725193,"eighty":-2.964833,"marketCap":8457252665},{"date":"2024-02-02","current":-8.229399,"twenty":-7.069423,"median":-4.752459,"eighty":-2.973569,"marketCap":8079409627},{"date":"2024-02-09","current":-8.655198,"twenty":-7.254542,"median":-4.792407,"eighty":-2.978932,"marketCap":8497448732},{"date":"2024-02-16","current":2.065844,"twenty":-7.303922,"median":-4.780228,"eighty":-2.964833,"marketCap":9226936768},{"date":"2024-02-23","current":2.049606,"twenty":-7.257183,"median":-4.752459,"eighty":-2.914323,"marketCap":9154410628},{"date":"2024-03-01","current":2.06404,"twenty":-7.238464,"median":-4.725193,"eighty":-2.857709,"marketCap":9218878308},{"date":"2024-03-08","current":2.011717,"twenty":-7.203572,"median":-4.702881,"eighty":-2.831089,"marketCap":8985182966},{"date":"2024-03-15","current":1.845728,"twenty":-7.17056,"median":-4.682797,"eighty":-2.784203,"marketCap":8243804641},{"date":"2024-03-22","current":1.851141,"twenty":-7.072124,"median":-4.662035,"eighty":-2.734408,"marketCap":8267980021},{"date":"2024-03-28","current":1.955786,"twenty":-7.061318,"median":-4.653949,"eighty":-2.724231,"marketCap":8735370705},{"date":"2024-04-05","current":2.07667,"twenty":-7.041464,"median":-4.649343,"eighty":-2.647672,"marketCap":9275287529},{"date":"2024-04-12","current":2.015326,"twenty":-6.982171,"median":-4.633193,"eighty":-2.603013,"marketCap":9001299887},{"date":"2024-04-19","current":1.869183,"twenty":-6.836309,"median":-4.627992,"eighty":-2.577493,"marketCap":8348564622},{"date":"2024-04-26","current":1.963003,"twenty":-6.71354,"median":-4.606312,"eighty":-2.558353,"marketCap":8767604545},{"date":"2024-05-03","current":2.027955,"twenty":-6.670861,"median":-4.599453,"eighty":-2.532833,"marketCap":9057709107},{"date":"2024-05-10","current":2.02976,"twenty":-6.650279,"median":-4.593193,"eighty":-2.494554,"marketCap":9065767567},{"date":"2024-05-17","current":2.058627,"twenty":-6.642371,"median":-4.533273,"eighty":-2.462654,"marketCap":9194702928},{"date":"2024-05-24","current":1.973829,"twenty":-6.591446,"median":-4.51,"eighty":-2.454908,"marketCap":8815955305},{"date":"2024-05-31","current":1.718448,"twenty":-6.564974,"median":-4.500113,"eighty":-2.434582,"marketCap":7675319574},{"date":"2024-06-07","current":1.803946,"twenty":-6.454764,"median":-4.494023,"eighty":-2.405157,"marketCap":7845225590},{"date":"2024-06-14","current":1.83622,"twenty":-6.411262,"median":-4.475755,"eighty":-2.37522,"marketCap":7985582733},{"date":"2024-06-21","current":1.834521,"twenty":-6.357491,"median":-4.458443,"eighty":-2.36232,"marketCap":7978195515},{"date":"2024-06-28","current":1.795452,"twenty":-6.315456,"median":-4.451397,"eighty":-2.359299,"marketCap":7808289499},{"date":"2024-07-05","current":1.780165,"twenty":-6.293959,"median":-4.43381,"eighty":-2.336521,"marketCap":7741804537},{"date":"2024-07-12","current":1.909261,"twenty":-6.284629,"median":-4.411894,"eighty":-2.31496,"marketCap":8303233110},{"date":"2024-07-15","current":1.927946,"twenty":-6.281626,"median":-4.40302,"eighty":-2.312728,"marketCap":8384492509},{"date":"2024-08-02","current":1.805074,"twenty":-6.278622,"median":-4.39535,"eighty":-2.309536,"marketCap":7850132402},{"date":"2024-08-09","current":1.693429,"twenty":-6.278622,"median":-4.366072,"eighty":-2.252116,"marketCap":8020144685},{"date":"2024-08-16","current":1.766031,"twenty":-6.246992,"median":-4.329608,"eighty":-2.236408,"marketCap":8363991829},{"date":"2024-08-23","current":1.823806,"twenty":-6.191639,"median":-4.316807,"eighty":-2.107879,"marketCap":8637614904},{"date":"2024-08-30","current":1.876896,"twenty":-6.183731,"median":-4.292175,"eighty":-2.071549,"marketCap":8889052324},{"date":"2024-09-06","current":1.903441,"twenty":-6.177405,"median":-4.262355,"eighty":-2.013004,"marketCap":9014771034},{"date":"2024-09-13","current":1.892511,"twenty":-6.151768,"median":-4.223516,"eighty":-1.918435,"marketCap":8963004506},{"date":"2024-09-20","current":1.861281,"twenty":-6.131704,"median":-4.204376,"eighty":1.697441,"marketCap":8815100142},{"date":"2024-09-27","current":1.806629,"twenty":-6.122015,"median":-4.064326,"eighty":1.738237,"marketCap":8556267503},{"date":"2024-10-04","current":1.750416,"twenty":-6.120471,"median":-4.028928,"eighty":1.751704,"marketCap":8290039647},{"date":"2024-10-11","current":1.853474,"twenty":-6.110279,"median":-4.000218,"eighty":1.762284,"marketCap":8778124050},{"date":"2024-10-18","current":1.85972,"twenty":-6.083958,"median":-3.901446,"eighty":1.777262,"marketCap":8807704923},{"date":"2024-10-25","current":1.842543,"twenty":-6.072558,"median":-3.879584,"eighty":1.781575,"marketCap":8726357523},{"date":"2024-10-31","current":1.83942,"twenty":-6.056813,"median":-3.805687,"eighty":1.791991,"marketCap":8711567086},{"date":"2024-11-08","current":1.836298,"twenty":-6.043338,"median":-3.726587,"eighty":1.795307,"marketCap":8696776650},{"date":"2024-11-15","current":1.761541,"twenty":-6.022157,"median":-3.710504,"eighty":1.796132,"marketCap":8473335020},{"date":"2024-11-22","current":1.788782,"twenty":-5.980856,"median":-3.669625,"eighty":1.795452,"marketCap":8604365974},{"date":"2024-11-29","current":1.92347,"twenty":-5.959401,"median":-3.641728,"eighty":1.799135,"marketCap":9252241246},{"date":"2024-12-06","current":1.828129,"twenty":-5.955617,"median":-3.621995,"eighty":1.805651,"marketCap":8793632907},{"date":"2024-12-13","current":1.797862,"twenty":-5.950068,"median":-3.584982,"eighty":1.808349,"marketCap":8648042958},{"date":"2024-12-20","current":1.740355,"twenty":-5.940624,"median":-3.556632,"eighty":1.808807,"marketCap":8371422056},{"date":"2024-12-27","current":1.816022,"twenty":-5.937226,"median":-3.538361,"eighty":1.814437,"marketCap":8735396928},{"date":"2025-01-03","current":1.828129,"twenty":-5.937226,"median":-3.502516,"eighty":1.814437,"marketCap":8793632907},{"date":"2025-01-10","current":1.667714,"twenty":-5.936463,"median":-3.489823,"eighty":1.814437,"marketCap":8022006178},{"date":"2025-01-17","current":1.64804,"twenty":-5.931806,"median":-3.459421,"eighty":1.81012,"marketCap":7927372712},{"date":"2025-01-24","current":1.696467,"twenty":-5.919996,"median":-3.442407,"eighty":1.808689,"marketCap":8160316630},{"date":"2025-01-31","current":1.720681,"twenty":-5.911027,"median":-3.427114,"eighty":1.808297,"marketCap":8276788589},{"date":"2025-02-07","current":1.645013,"twenty":-5.893917,"median":-3.410632,"eighty":1.807254,"marketCap":7912813717},{"date":"2025-02-14","current":-63.938672,"twenty":-5.936654,"median":-3.427114,"eighty":1.806273,"marketCap":7456591836},{"date":"2025-02-21","current":-65.590676,"twenty":-5.950068,"median":-3.43596,"eighty":1.805651,"marketCap":7649250189},{"date":"2025-02-28","current":-63.510374,"twenty":-6.028354,"median":-3.459421,"eighty":1.804623,"marketCap":7406643374},{"date":"2025-03-07","current":-64.856452,"twenty":-6.095845,"median":-3.489823,"eighty":1.803146,"marketCap":7563624254},{"date":"2025-03-14","current":-63.755116,"twenty":-6.138729,"median":-3.504703,"eighty":1.801321,"marketCap":7435185352},{"date":"2025-03-21","current":-67.120309,"twenty":-6.224851,"median":-3.540051,"eighty":1.799375,"marketCap":7827637554},{"date":"2025-03-28","current":-64.122228,"twenty":-6.294119,"median":-3.568302,"eighty":1.797622,"marketCap":7477998319},{"date":"2025-04-04","current":-61.246517,"twenty":-6.57821,"median":-3.611042,"eighty":1.797217,"marketCap":7142630074},{"date":"2025-04-11","current":-59.043845,"twenty":-6.696468,"median":-3.629292,"eighty":1.796471,"marketCap":6885752269},{"date":"2025-04-17","current":-61.307702,"twenty":-7.029605,"median":-3.656118,"eighty":1.795452,"marketCap":7149765569},{"date":"2025-04-25","current":-67.303865,"twenty":-7.203572,"median":-3.697571,"eighty":1.795404,"marketCap":7849044038},{"date":"2025-05-02","current":-70.852614,"twenty":-7.3427,"median":-3.722442,"eighty":1.794996,"marketCap":8262902723},{"date":"2025-05-09","current":-67.487421,"twenty":-7.407161,"median":-3.747314,"eighty":1.793826,"marketCap":7870450521},{"date":"2025-05-16","current":-65.835417,"twenty":-7.440032,"median":-3.863192,"eighty":1.792576,"marketCap":7677792168},{"date":"2025-05-23","current":-66.936753,"twenty":-7.514009,"median":-3.898058,"eighty":1.792422,"marketCap":7806231070},{"date":"2025-05-30","current":-44.666612,"twenty":-7.615264,"median":-3.996029,"eighty":1.791808,"marketCap":7681808591},{"date":"2025-06-06","current":-44.271332,"twenty":-7.828164,"median":-4.012794,"eighty":1.791601,"marketCap":7613827984},{"date":"2025-06-13","current":-45.338588,"twenty":-7.985677,"median":-4.058168,"eighty":1.790295,"marketCap":7797375622},{"date":"2025-06-20","current":-45.220004,"twenty":-8.052528,"median":-4.089537,"eighty":1.789085,"marketCap":7776981440},{"date":"2025-06-27","current":-45.852451,"twenty":-8.132775,"median":-4.212332,"eighty":1.786858,"marketCap":7885750412},{"date":"2025-07-03","current":-43.441245,"twenty":-8.195007,"median":-4.226706,"eighty":1.786004,"marketCap":7471068709},{"date":"2025-07-11","current":-45.733867,"twenty":-8.236009,"median":-4.268175,"eighty":1.785163,"marketCap":7865356229},{"date":"2025-07-18","current":-46.050091,"twenty":-8.440661,"median":-4.304491,"eighty":1.782373,"marketCap":7919740715},{"date":"2025-07-25","current":-44.982836,"twenty":-8.475052,"median":-4.317429,"eighty":1.780409,"marketCap":7736193076},{"date":"2025-08-01","current":-44.90378,"twenty":-8.532372,"median":-4.34784,"eighty":1.780165,"marketCap":7722596955},{"date":"2025-08-08","current":-45.837033,"twenty":-8.611161,"median":-4.372234,"eighty":1.779146,"marketCap":7883098769},{"date":"2025-08-15","current":-16.34542,"twenty":-8.663439,"median":-4.411894,"eighty":1.777563,"marketCap":8019602644},{"date":"2025-08-22","current":-16.428886,"twenty":-8.766224,"median":-4.43381,"eighty":1.776024,"marketCap":8060553806},{"date":"2025-08-29","current":-16.618548,"twenty":-8.845327,"median":-4.45492,"eighty":1.774463,"marketCap":8153608011},{"date":"2025-09-05","current":-17.495406,"twenty":-8.854277,"median":-4.470178,"eighty":1.771946,"marketCap":8583823509},{"date":"2025-09-12","current":-20.056388,"twenty":-8.876687,"median":-4.494023,"eighty":1.769108,"marketCap":9840325916},{"date":"2025-09-19","current":-21.002838,"twenty":-8.897577,"median":-4.500113,"eighty":1.767877,"marketCap":10304685501},{"date":"2025-09-26","current":-20.821899,"twenty":-8.942703,"median":-4.512292,"eighty":1.764235,"marketCap":10215910875},{"date":"2025-10-03","current":-22.241574,"twenty":-9.033505,"median":-4.556436,"eighty":1.761541,"marketCap":10912450253},{"date":"2025-10-10","current":-22.436432,"twenty":-9.13201,"median":-4.593552,"eighty":1.761463,"marketCap":11008053697},{"date":"2025-10-17","current":-24.093621,"twenty":-9.171002,"median":-4.599453,"eighty":1.761347,"marketCap":11821125436},{"date":"2025-10-24","current":-25.515863,"twenty":-9.267695,"median":-4.606312,"eighty":1.759121,"marketCap":12518924190},{"date":"2025-10-31","current":-27.571776,"twenty":-9.314846,"median":-4.630267,"eighty":1.753849,"marketCap":13527623380},{"date":"2025-11-07","current":-28.965855,"twenty":-9.38078,"median":-4.633845,"eighty":1.750842,"marketCap":14211604337},{"date":"2025-11-14","current":-38.236714,"twenty":-16.050507,"median":-4.650846,"eighty":1.750577,"marketCap":14299307604},{"date":"2025-11-21","current":-37.697383,"twenty":-16.342611,"median":-4.655501,"eighty":1.750416,"marketCap":14097615036},{"date":"2025-11-28","current":-38.701655,"twenty":-16.456526,"median":-4.665632,"eighty":1.749791,"marketCap":14473180508},{"date":"2025-12-05","current":-39.389767,"twenty":-16.615764,"median":-4.682797,"eighty":1.746981,"marketCap":14730512405},{"date":"2025-12-12","current":-39.687329,"twenty":-17.4453,"median":-4.707155,"eighty":1.745262,"marketCap":14841791064},{"date":"2025-12-19","current":-40.524222,"twenty":-18.606093,"median":-4.731811,"eighty":1.743078,"marketCap":15154762290},{"date":"2025-12-26","current":-41.844653,"twenty":-19.597082,"median":-4.752459,"eighty":1.741868,"marketCap":15648561337},{"date":"2026-01-02","current":-40.356843,"twenty":-20.471156,"median":-4.780228,"eighty":1.740658,"marketCap":15092168045},{"date":"2026-01-09","current":-40.505624,"twenty":-20.947164,"median":-4.79799,"eighty":1.739144,"marketCap":15147807374},{"date":"2026-01-16","current":-43.332463,"twenty":-21.144805,"median":-4.80726,"eighty":1.736859,"marketCap":16204954629},{"date":"2026-01-23","current":-42.718742,"twenty":-22.269411,"median":-4.820349,"eighty":1.732402,"marketCap":15975442396},{"date":"2026-01-30","current":-40.951967,"twenty":-22.464268,"median":-4.839442,"eighty":1.729057,"marketCap":15314725362},{"date":"2026-02-06","current":-39.315377,"twenty":-23.265544,"median":-4.869723,"eighty":1.723844,"marketCap":14702692741},{"date":"2026-02-13","current":-23.658007,"twenty":-23.992234,"median":-4.895928,"eighty":1.719341,"marketCap":19145005414},{"date":"2026-02-20","current":-24.339004,"twenty":-24.150641,"median":-4.920298,"eighty":1.716464,"marketCap":19696095290},{"date":"2026-02-27","current":-25.196883,"twenty":-24.32534,"median":-4.934107,"eighty":1.712733,"marketCap":20390325393},{"date":"2026-03-06","current":-26.284709,"twenty":-24.763521,"median":-4.942241,"eighty":1.709179,"marketCap":21270637791},{"date":"2026-03-13","current":-25.249947,"twenty":-25.183659,"median":-4.969264,"eighty":1.701915,"marketCap":20433267461},{"date":"2026-03-20","current":-24.586639,"twenty":-25.109832,"median":-4.983292,"eighty":1.695862,"marketCap":19896491608},{"date":"2026-03-27","current":-24.188654,"twenty":-25.021769,"median":-4.998522,"eighty":1.694344,"marketCap":19574426096},{"date":"2026-04-02","current":-24.622015,"twenty":-25.007618,"median":-5.002736,"eighty":1.692826,"marketCap":19925119654},{"date":"2026-04-10","current":-25.188039,"twenty":-25.025307,"median":-5.016381,"eighty":1.690111,"marketCap":20383168381},{"date":"2026-04-17","current":-25.815971,"twenty":-25.183196,"median":-5.064808,"eighty":1.688901,"marketCap":20891316189},{"date":"2026-04-24","current":-24.887339,"twenty":-25.282435,"median":-5.111198,"eighty":1.688598,"marketCap":20139829995},{"date":"2026-05-01","current":-25.232259,"twenty":-25.246409,"median":-5.124441,"eighty":1.687387,"marketCap":20418953438},{"date":"2026-05-08","current":-25.011156,"twenty":-25.246409,"median":-5.154305,"eighty":1.687084,"marketCap":20240028154},{"date":"2026-05-15","current":-26.090138,"twenty":-25.432136,"median":-5.182132,"eighty":1.685571,"marketCap":21113183541},{"date":"2026-05-22","current":-74.093456,"twenty":-25.510438,"median":-5.208301,"eighty":1.684361,"marketCap":22211069488},{"date":"2026-05-29","current":-71.694057,"twenty":-25.612556,"median":-5.218669,"eighty":1.684361,"marketCap":21491799103},{"date":"2026-06-05","current":-70.854267,"twenty":-25.780594,"median":-5.241738,"eighty":1.67528,"marketCap":21240054469},{"date":"2026-06-12","current":-71.334147,"twenty":-25.904412,"median":-5.249117,"eighty":1.667714,"marketCap":21383908546},{"date":"2026-06-18","current":-74.861264,"twenty":-26.01231,"median":-5.261244,"eighty":1.66166,"marketCap":22441236012},{"date":"2026-06-26","current":-81.627571,"twenty":-26.182117,"median":-5.279742,"eighty":1.656515,"marketCap":24469578497},{"date":"2026-07-02","current":-84.050964,"twenty":-26.39603,"median":-5.299965,"eighty":1.651067,"marketCap":25196041586},{"date":"2026-07-10","current":-88.321895,"twenty":-27.752021,"median":-5.30757,"eighty":1.646224,"marketCap":26476342871},{"date":"2026-07-17","current":-81.411625,"twenty":-32.332003,"median":-5.32219,"eighty":1.642289,"marketCap":24404844163},{"date":"2026-07-24","current":-84.218922,"twenty":-37.663907,"median":-5.347277,"eighty":1.631393,"marketCap":25246390513},{"date":"2026-07-31","current":-82.82727,"twenty":-37.797811,"median":-5.358727,"eighty":1.622918,"marketCap":24829213690},{"date":"2026-08-07","current":-94.875085,"twenty":-38.206958,"median":-5.382072,"eighty":1.615049,"marketCap":25260775921},{"date":"2026-08-14","current":-98.424728,"twenty":-38.701655,"median":-5.392973,"eighty":0.248111,"marketCap":26205878984},{"date":"2026-08-21","current":-99.943963,"twenty":-39.021534,"median":-5.411741,"eighty":-1.795313,"marketCap":26610379872},{"date":"2026-08-28","current":-101.951523,"twenty":-39.52367,"median":-5.426692,"eighty":-1.838624,"marketCap":27144898903},{"date":"2026-09-04","current":-93.351568,"twenty":-40.200623,"median":-5.456159,"eighty":-1.908142,"marketCap":24855134946},{"date":"2026-09-11","current":-111.066933,"twenty":-40.338245,"median":-5.485637,"eighty":-1.928042,"marketCap":29571904234},{"date":"2026-09-18","current":-108.462531,"twenty":-40.687881,"median":-5.523143,"eighty":-1.950427,"marketCap":28878474139},{"date":"2026-09-25","current":-98.01779,"twenty":-40.84782,"median":-5.541411,"eighty":-1.975048,"marketCap":26097530531},{"date":"2026-10-02","current":-96.30865,"twenty":-41.123065,"median":-5.56694,"eighty":-1.994349,"marketCap":25642467032},{"date":"2026-10-07","current":-96.390038,"twenty":-41.710751,"median":-5.614485,"eighty":-1.994349,"marketCap":25664136722}],"updateTime":1791457765962},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ROIV\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669485368","title":"Roivant（ROIV）跌2.93% 皮膚紅斑狼瘡試驗失利","url":"https://stock-news.laohu8.com/highlight/detail?id=2669485368","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669485368?lang=zh_tw&edition=fundamental","pubTime":"2026-09-23 20:06","pubTimestamp":1790165207,"startTime":"0","endTime":"0","summary":"金吾财讯 | Roivant Sciences 美股盘前股价承压，最新跌2.93%，报37.1美元。消息面上，Roivant旗下子公司Immunovant的在研药物IMVT-1402针对皮肤自身免疫疾病-皮肤红斑狼疮的概念验证临床试验宣告失败。公司公布的12周试验数据显示，这项纳入57名受试者的研究，未能达成基于皮肤红斑狼疮疾病面积与严重程度活动指数评分设定的主要终点。受本次试验结果以及皮肤红斑狼疮领域行业竞争影响，Immunovant将不再继续推进IMVT-1402项目。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/NmJhNzAzYmFlYjJhNGNmZDhhMTE1NWJmMTYxODM5M2UxMzU2NDM2MDM2MQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NmJhNzAzYmFlYjJhNGNmZDhhMTE1NWJmMTYxODM5M2UxMzU2NDM2MDM2MQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306391","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","IMVT","ROIV","BK4007","BK4588","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669834264","title":"Immunovant股價因狼瘡藥物研發受挫而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2669834264","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669834264?lang=zh_tw&edition=fundamental","pubTime":"2026-09-23 20:04","pubTimestamp":1790165075,"startTime":"0","endTime":"0","summary":"BUZZ-Immunovant股价因狼疮药物研发受挫而下跌9月23日-** 生物技术公司Immunovant（IMVT.O）的股价在盘前交易中下跌4.5%，至35.6美元** 若跌势持续，该股开盘价将创下三个多月来的新低** 由于该药物在研究的主要目标上未能达到统计学显著性，公司计划停止 (link) 针对皮肤型红斑狼疮（CLE）的IMVT-1402药物研发** CLE是一种自身免疫性皮肤病，会引","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL4S45F0TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT","BK4585","PTH","BK4007","BK4139","ROIV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190669999","title":"Roivant公布Imvt-1402在皮膚紅斑狼瘡概念驗證研究中的頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1190669999","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190669999?lang=zh_tw&edition=fundamental","pubTime":"2026-09-23 19:01","pubTimestamp":1790161275,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.今日宣布，其针对皮肤红斑狼疮（CLE）的在研药物Imvt-1402已完成概念验证研究，并取得顶线结果。该项研究的数据表明，该药物在主要疗效终点上展现出具有临床意义的改善，同时安全性与耐受性表现良好。公司表示，详细数据将在未来的医学会议上予以公布。这一进展为皮肤红斑狼疮患者群体带来了新的治疗希望，也标志着Roivant在炎症与免疫领域的研发管线又迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTH","BK4007","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375206","title":"BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375206","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:58","pubTimestamp":1788875887,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-Sigma Lithium、Shake Shack、诺华工作区中用于查询单只股票行情的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB8路透9月8日-周二开盘时，华尔街主要股指涨跌不一，中东地区新一轮冲突推动油价升至7月下旬以来的最高水平，而市场正在等待本周晚些时候","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S45014M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","LU2089984988.USD","BK4139","LU1989764748.USD","BK4505","LU1791710400.SGD","PPH","BK4567","BK4534","IBB","IE00BJT1NW94.SGD","BEX","BK4182","OIH","IE00BFTCPJ56.SGD","GNOM","LU0823417653.USD","IE0002270589.USD","LU1720051108.HKD","LU0234572021.USD","MEDX","IE000M9KFDE8.USD","BBH","CQTM","IE00B19Z3B42.SGD","LU0889565916.HKD","SG9999011175.SGD","IE00B19Z4B17.USD","LU0320765992.SGD","BK4504","LU0433182093.SGD","LU2249611893.SGD","LU0320765489.SGD","SHAK","SRPT","IE00B3T34201.USD","HYDR","LU2112291526.USD","LU0267386448.USD","LU0122379950.USD","BK4533","LU1989772923.USD","LU0114720955.EUR","LU2098885051.SGD","LU1804176565.USD","LU2491050071.SGD","OZEM","SIMS","LU1989764664.SGD","IONL","LU0321505439.SGD","BK4124","LU2491049909.HKD","BK4578","LU0353189763.USD","LU0306807586.USD","LU1489326972.SGD","ABM","BK4588","LU0882574055.USD","LU1720051017.SGD","PFE","SRPU","IONX","LU1571399168.USD","BK4170","RGTI","AMGN","BK4550","BK4599","LU0068578508.USD","WQTM","BEG","LU1064131342.USD","LU1983299246.USD","LU2491050154.USD","SG9999001440.SGD","SG9999003800.SGD","ZAP","IONZ","IBBQ","CTEC","LU0345769128.USD","CHRW","RGTC","LU1066051498.USD","LU2242649171.HKD","LU1366192091.USD","LU0985489474.SGD","PTH","IOYY","LU1894683264.USD","LU2294711713.HKD","LU2506952170.USD","LU0528227936.USD","LU2596442595.SGD","SG9999002224.SGD","LU0077335932.USD","SMOG","04332","IE0034235188.USD","LU0289739699.SGD","LU0353189680.USD","BHVN","LU1093756325.SGD","SG9999002232.USD","LU0251132253.USD","LU1023059063.AUD","IE0009354923.USD","VCLN","IE0031619046.USD","BK4585","LU0058720904.USD","LU0444973449.USD","VTWG","LU0432979614.USD","LU2362541513.USD","SG9999001176.USD","ILMN","BK4082","BK4541","IE00BBT3K403.USD","LU1861559042.SGD","LU0187121727.USD","BK4532","LU0985481810.HKD","IBAT","LU0238689110.USD","LU1883839398.USD","WATS","LU0823414551.USD","LU0225771236.USD","LU1153585028.USD","RGYY","BK4168","IE00B66KJ199.SGD","LU1815336760.USD","LU0109394709.USD","IE00B2B36J28.USD","LU0306806265.USD","LU2242652126.USD","PHVS","LU1894683348.USD","LU2506951958.HKD","FRNW","BK4566","UPGR","LU0128526141.USD","LU1861558580.USD","RGTU","BK4602","LU0868494617.USD","LU0823417737.USD","SG9999001176.SGD","BIB","LU1061106388.HKD","ALV","ICLN","LU0138981039.USD","NTLA","IE00BLSP4239.USD","LU2362541273.HKD","BK4121","CNRG","UNFI","LU2357125470.USD","LU2468319806.SGD","BK4592","LU2506951875.HKD","LU0048584097.USD","LU2362540622.SGD","LU1066053197.SGD","LU0950375773.USD","LU2244417387.USD","LU0476273544.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4568","LU1791710582.SGD","BK4102","BSX","IE0002141913.USD","BE","LU0029874061.USD","LU1878469433.USD","PJP","IE0009355771.USD","BK4556","TBXU","BEC","BK4131","LU0456855351.SGD","LU0823416689.USD","LU1057294990.SGD","BK4141","LU0444971666.USD","GNMX","LU1988902786.USD","LU1989771016.USD","PBE","LU0823414478.USD","LU0208291251.USD","DYN","LU0321505868.SGD","LU1093756168.USD","BEZ","IONC","LU1548497426.USD","BK4535","BK4548","LU1718418525.SGD","LU0170899867.USD","LU0957808578.USD","LU0011850046.USD","LU1291159041.SGD","LU2506952097.USD","LU0345769631.USD","BK4179","LU0211331839.USD","BK4581","IONS","IE00BJJMRZ35.SGD","LU0070302665.USD","LU2087625088.SGD","BK4591","LU2265009873.SGD","LU2506951792.HKD","NVS","SG9999013999.USD","BK4007","LU2324357040.USD","IE00B7SZL793.SGD","IE00BLSP4452.SGD","QTUP","USNG","EGGY","SEI","SGML","IONQ","LU0225284248.USD","LU0878866978.SGD","BK4209","LU2543165471.USD","LU1303367103.USD","LU0225283273.USD","LU1642822529.SGD","LU1989772840.SGD","RGTZ","LU2357305700.SGD","RGTX","BK4120","IE00B4R5TH58.HKD","LU2242646821.SGD","LU2264538146.SGD","XES","ROIV","BK4597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195156658","title":"異動解讀｜Roivant Sciences盤中上漲14.2%，核心管線Mosliciguat二期臨床達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=1195156658","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195156658?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:30","pubTimestamp":1788874228,"startTime":"0","endTime":"0","summary":"9月8日，Roivant Sciences盘中上涨14.2%，报39.9美元/股，成交额3711.26万美元。消息面上，公司旗下Pulmovant部门宣布其吸入式sGC激活剂Mosliciguat在间质性肺病相关肺动脉高压患者中开展的二期PHocus研究达到主要及次要终点。药物安全性良好，疗效持续改善。公司同时披露已启动Phrontier三期研究，推动Mosliciguat向注册阶段迈进。Roivant Sciences是一家生物制药公司，核心管线包括处于FDA审查阶段的brepocitinib、靶向FcRn的IMVT-1402以及Mosliciguat。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Roivant大涨，肺高压新药疗效亮眼","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665802322","title":"Roivant公司實驗性肺部疾病藥物在中期研究中達到預期目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665802322","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665802322?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865191,"startTime":"0","endTime":"0","summary":"Roivant公司实验性肺部疾病药物在中期研究中达到预期目标路透9月8日-Roivant公司周二表示，其试验性药物在针对一种肺部疾病相关高血压患者的中期研究中达到了主要目标，受此消息提振，该公司股价在盘前交易中上涨约20%。继上月获得美国批准用于治疗皮肤和肌肉疾病的药物Lisraya后，Roivant一直在扩充其后期研发管线。Roivant表示，该公司已启动一项后期临床试验，计划在全球范围内招募约375名患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4500RV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","PTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192184963","title":"實驗性肺病藥物中期研究達主要終點 Roivant Sciences股價盤前飆升21.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192184963","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192184963?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:11","pubTimestamp":1788862270,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.股价在盘前交易中大涨21.1%，此前该公司宣布其研发的一款针对肺部疾病的实验性药物，在一项中期研究中成功达到了主要疗效终点。这一积极进展显著提振了市场信心，推动股价迅速走高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ROIV","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103996547","title":"異動解讀｜Roivant Sciences盤前上漲28.66%，核心管線Mosliciguat臨床研究獲積極數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1103996547","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103996547?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:06","pubTimestamp":1788861984,"startTime":"0","endTime":"0","summary":"9月8日，Roivant Sciences盘前上涨28.66%，报44.92美元/股，成交额14.04万美元。消息面上，公司宣布其吸入式sGC激活剂Mosliciguat在间质性肺病相关肺动脉高压患者中开展的Phocus研究取得积极结果，数据验证了药物的有效性。PH-ILD长期缺乏有效疗法，Mosliciguat的积极数据为该领域带来潜在突破。Roivant Sciences是一家生物制药公司，核心管线包括处于FDA审查阶段的brepocitinib、靶向FcRn的IMVT-1402以及本次获得积极数据的Mosliciguat。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Mosliciguat临床数据积极，Roivant盘前大涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102884849","title":"Roivant公布Mosliciguat治療間質性肺病相關肺動脈高壓（Ph-Ild）的Phocus研究積極結果，並披露正在進行的Phrontier III期試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1102884849","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102884849?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:01","pubTimestamp":1788861671,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.今日宣布，其针对Mosliciguat在间质性肺病相关肺动脉高压患者中的Phocus研究取得了振奋人心的积极成果。与此同时，该公司还揭开了正在推进的Phrontier III期研究的面纱，这一举措标志着该候选药物在临床开发道路上又迈出了坚实一步。据悉，Phocus研究的数据不仅验证了药物的有效性，还为这一长期缺乏有效疗法的罕见病症带来了新的希望之光。值得注意的是，Phrontier III期研究的启动，无疑将进一步巩固Mosliciguat在该适应症领域的潜在治疗地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ROIV","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662965140","title":"Roivant和Priovant推出新獲批的罕見病藥物Lisraya，每月售價35,000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662965140","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662965140?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 21:43","pubTimestamp":1787924608,"startTime":"0","endTime":"0","summary":"更新 1-Roivant和Priovant推出新获批的罕见病药物Lisraya，每月售价35,000美元全文补充了详细信息和背景路透8月28日-Roivant公司及其合作伙伴Priovant Therapeutics于周五将新获批的罕见病药物Lisraya的30天用量定价为35,000美元。皮肌炎是一种罕见疾病，会引起疼痛性皮疹和进行性肌肉无力。Roivant持有Priovant 71%的股权，而辉瑞持有24%的股份。合作方预计，Lisraya在美国的市场独占权将至少持续至2039年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4S44P14K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PTH","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141500682","title":"Priovant宣佈FDA批准Lisraya™（Brepocitinib）用於成人皮肌炎治療；現已在美國上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1141500682","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141500682?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 03:29","pubTimestamp":1787858949,"startTime":"0","endTime":"0","summary":"Priovant今日宣布，美国食品药品监督管理局（FDA）已正式批准Lisraya™（Brepocitinib）用于治疗成人皮肌炎患者。这一里程碑式的决定意味着该药物现已即刻在美国市场供应。\n皮肌炎是一种罕见的自身免疫性疾病，以肌肉无力和特征性皮疹为主要表现，长期以来困扰着众多患者。此次获批为这一患者群体带来了全新的治疗选择。\nLisraya™作为一种创新疗法，其获批上市标志着皮肌炎治疗领域取得了重大突破。该药物目前已可及，符合条件的患者将能够立即获得这一新的治疗方案的处方。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4139","BK4007","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662308069","title":"美國FDA批准了Roivant-Priovant公司的一款皮膚病藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2662308069","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662308069?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 03:26","pubTimestamp":1787858803,"startTime":"0","endTime":"0","summary":"美国FDA批准了Roivant-Priovant公司的一款皮肤病药物路透8月27日-美国食品和药物管理局周四表示，已批准Roivant公司（ROIV.O）及其合作伙伴Priovant Therapeutics公司研发的一种用于治疗皮肌炎的药物，这使其成为首款用于治疗该皮肤病的口服药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O1TT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","PTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169456208","title":"《JAMA皮膚病學》發布Brepocitinib治療皮肌炎3期VALOR試驗皮膚特異性結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1169456208","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169456208?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 23:12","pubTimestamp":1787757130,"startTime":"0","endTime":"0","summary":"《JAMA皮肤病学》杂志正式刊发了Brepocitinib在皮肌炎治疗中的3期VALOR试验皮肤特异性结局数据。这项研究聚焦于皮肤相关症状的改善情况，为这一罕见自身免疫性疾病的治疗提供了新的临床证据。该试验结果此前已引起业界广泛关注，如今皮肤特异性数据的公布，进一步丰富了人们对Brepocitinib疗效维度的理解。皮肌炎以皮肤和肌肉炎症为特征，皮肤表现往往对患者生活质量造成显著影响，因此这一数据的发布具有重要临床意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTH","ROIV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187698206","title":"Roivant Sciences：Brepocitinib新藥申請獲批，皮肌炎產品預計2026年9月底前上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1187698206","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187698206?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 19:29","pubTimestamp":1786015777,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. 传来重磅消息。其研发的Brepocitinib，在针对皮肌炎的治疗上，已提交新药申请（NDA）。公司预计，该药物有望在2026年9月底前获得批准，并正式推向市场。这无疑是一个关键节点，标志着这家生物制药公司，在自身免疫疾病领域的布局迈出了坚实一步。皮肌炎作为一种罕见的自身免疫性疾病，一直缺乏有效的治疗手段。Brepocitinib若能如期获批，将为患者带来新的希望。目前，市场正密切关注这一进展，并期待其最终结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4007","BK4139","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176010812","title":"財報前瞻｜Roivant Sciences Ltd.本季度營收預計大幅下滑，機構觀點偏謹慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1176010812","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176010812?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 10:01","pubTimestamp":1785376902,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.计划于2026年08月06日发布财报，市场聚焦费用端收缩与在研管线推进节奏对利润和现金流的影响。根据一致预期，本季度Roivant Sciences Ltd.预计总营收为2.06百万美元，同比下降71.57%；预计调整后每股收益为-0.32美元，同比变化为-2.18%；预计EBIT为-3.07亿美元，同比改善19.95%。基于近六个月的公开研报与观点收集，机构整体对Roivant Sciences Ltd.的短期基本面持偏谨慎态度，看空与中性观点合计比例高于看多。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Roivant Sciences Ltd.本季度营收预计大幅下滑，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170932235","title":"Roivant Sciences 將於2026年8月6日公布第一財季業績並更新業務動態","url":"https://stock-news.laohu8.com/highlight/detail?id=1170932235","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170932235?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 04:06","pubTimestamp":1784837181,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.（ROIV）计划于2026年8月6日（周四）发布截至同年6月30日的第一财季财务报告。届时，公司还将同步提供最新的业务进展动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","PTH","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150102941","title":"異動解讀 | Roivant Sciences盤中大漲15.99%，財報及關節炎藥物進展提振股價","url":"https://stock-news.laohu8.com/highlight/detail?id=1150102941","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150102941?lang=zh_tw&edition=fundamental","pubTime":"2026-05-21 01:05","pubTimestamp":1779296717,"startTime":"0","endTime":"0","summary":"生物制药公司Roivant Sciences Ltd.（ROIV）今日盘中股价大幅上涨15.99%，表现强劲。消息面上，公司公布了截至2026年3月31日的第四季度及全年财务业绩，并同步更新了业务进展。尽管第四季度营收低于市场预期，但公司披露的业务动态获得了市场的积极评价。其中，路透社的市场快讯特别指出，其关节炎药物初步显示出积极效果，这一进展是推动股价走高的关键因素。Roivant Sciences是一家通过构建技术平台来加速开发变革性药物的公司，此次财报与研发进展的披露，显著增强了投资者对其未来增长潜力的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636829366","title":"市場快訊——美股行情動態-皇家加勒比郵輪、AMC娛樂、Roivant","url":"https://stock-news.laohu8.com/highlight/detail?id=2636829366","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636829366?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 23:44","pubTimestamp":1779291855,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数 .DJI 上涨0.72%，报49,717.21点。标普500指数 .SPX 上涨0.78%，报7,410.98点；纳斯达克综合指数 .IXIC 上涨1.18%，报26,175.20点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4S41X1IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FANG","OXY","AVGO","MEC","AKAM","EOG","PLUG","SNVD.UK","RAL","VIAV","CVS","AVGW","HUM","SITM","ELV","AVGG","RBLX","APA","RBLU","RCL","SNDK","CNC","WDC","CHRW","CAVA","AVGX","ROIV","AVGU","WDCX","NVDA","NVIW.SI","LCLN","TGT","PLUL","RBLY","LOW","TOL","ADI","AMC","MDLN","NEM","CVX","XOM","KEYS","VFC","DIPS","HAL","DVN","TJX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182026444","title":"異動解讀｜Roivant Sciences盤中上漲11.1%，公布財年業績及業務進展獲市場積極反應","url":"https://stock-news.laohu8.com/highlight/detail?id=1182026444","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182026444?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 21:40","pubTimestamp":1779284409,"startTime":"0","endTime":"0","summary":"5月20日，Roivant Sciences盘中上涨11.1%，报30.48美元/股，成交额3466.28万美元。消息面上，公司公布了截至3月31日的第四财季及全年财务业绩，并同步更新业务动态。尽管营收不及预期，但公司披露的业务进展获得市场积极反应，推动股价走强。Roivant Sciences是一家注册于百慕大的生物制药公司，通过构建技术平台和培养人才推出专注的生物制药及健康技术子公司，致力于更快开发变革性药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150457356","title":"異動解讀｜Roivant Sciences盤前上漲8.12%，公布財年業績及業務進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1150457356","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150457356?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 19:38","pubTimestamp":1779277123,"startTime":"0","endTime":"0","summary":"5月20日，Roivant Sciences盘前上涨8.12%，报30.43美元/股，成交额170.13万美元。消息面上，公司公布了截至3月31日的第四财季及全年财务业绩。数据显示，第四财季持续运营每股收益为0.28美元，营收252万美元低于市场预期的382万美元。尽管营收不及预期，但公司同步披露的业务动态更新获得市场积极反应，推动股价走强。Roivant Sciences是一家注册于百慕大的生物制药公司，通过构建技术平台和培养人才推出专注的生物制药及健康技术子公司，致力于更快开发变革性药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}